drugset
Drugs / GENEVAX IL-12
last change Aug 2015 re-read 3 minutes ago

GENEVAX IL-12

Other / unclassified

Developed for
HIV infectious disease
Investigated by
Auro Vaccines LLC · Ichor Medical Systems Incorporated · International AIDS Vaccine Initiative

Trials 1

today NCT01496989 · Ph 1
2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01496989 Dec 2011 → Mar 2013 HIV infectious disease International AIDS Vaccine Initiative Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as GENEVAX IL-12 “pDNA encoding human Interleukin 12 (IL-12) (GENEVAX IL-12) given by IM/EP” PMID 26252526 ↗ Aug 2015
1

NCT01496989 ↗
Modality Other / unclassified “pDNA encoding human Interleukin 12 (IL-12) (GENEVAX IL-12)” PMID 26252526 ↗ Aug 2015
Route Intramuscular “Co-administered with HIV-MAG, delivered intramuscularly by in vivo electroporation” NCT01496989 ↗